Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1147519
PUBLISHER: Grand View Research | PRODUCT CODE: 1147519
Clinical Trial Investigative Site Network Market Size, Share & Trends Analysis Report By Therapeutic Areas (Oncology, CNS), By Phase (Phase I, III), By End-use (Sponsor, CRO), By Region, And Segment Forecasts, 2022 - 2030
PUBLISHED:
PAGES: 275 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Clinical Trial Investigative Site Network Market Growth & Trends:
The global clinical trial investigative site network market size is expected to reach USD 12.5 billion by 2030, registering a CAGR of 6.0% over the forecast period, according to a new report by Grand View Research, Inc. Growing investments in pharmaceutical R&D, increasing demand for new therapies and complications associated with site management of clinical trials are some of the major factors driving the growth of the industry. There has been a consistent rise the clinical trials in the last 5 years. For instance, according to ClinicalTrials.gov, over 262,298 trials were registered in 2018, whereas as of September 2022, over 399,518 trials were registered. The clinical trials are expected to grow even further as the funding for research improves.
This is expected to propel the growth of the industry post-pandemic. There is a growing focus on reducing the cost associated with clinical research. Hiring a clinical trial investigative site network supports the regulatory function, improves the enrollment of participants, assists in data management, and quality assurance. It increases process compliance, reduces process issues with each trial, and helps with faster trial initiations, and shorter trial timelines. These factors are supporting the demand for clinical investigative site networks. The governments are actively trying to improve R&D by providing tax deductions. For instance, in January 2022, the Indian government stated that it is providing a weighted average tax deduction of up to 200% in R&D.
Such initiatives are expected to improve the R&D activities on drugs and thus support industry growth. According to the IQVIA, report on oncology trends, clinical trials for cancer have been increasing for the last 10 years. For instance, in 2011, 1,242 trials were registered for cancer, and as of 2021, 2,335 trials were registered for cancer. The number of clinical trials for cancer is expected to rise even further owing to the growing prevalence of the disease. This is expected to improve the demand for clinical investigative site networks for cancer clinical trials post-pandemic.
Clinical Trial Investigative Site Network Market Report Highlights:
- Based on therapeutic areas, the oncology segment held the largest revenue share in 2021. The growing number of clinical trials for cancer is one of the major factors supporting the segment growth
- The phase III segment led the industry in 2021 with the maximum revenue share as this phase includes a greater number of patients than other phases, thus supporting the demand for clinical investigative site network
- Based on end-use, the Contract Research Organizations (CROs) segment is anticipated to witness the fastest CAGR over the forecast period
- This is owing to the increasing number of partnerships among site networks and CROs for clinical studies
- Asia Pacific is anticipated to register the fastest CAGR over the forecast period due to a rise in the outsourcing of clinical trials in this region
Product Code: GVR-4-68039-986-6
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Therapeutic Areas
- 1.1.2. Phase
- 1.1.3. End Use
- 1.1.4. Regional scope
- 1.1.5. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.1.1. Approach 1: Commodity flow approach
- 1.6.1. Commodity flow analysis (Model 1)
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
- 1.9.1. Objective 1
- 1.9.2. Objective 2
Chapter 2. Executive Summary
- 2.1. Market Outlook
Chapter 3. Clinical Trial Investigative Site Network Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Market Dynamics
- 3.3.1. Market driver analysis
- 3.3.1.1. Increasing partnership amongst contract research sites, thereby boosting the growth of clinical trial investigative site networks
- 3.3.1.2. High prevalence of diseases worldwide contributing to the demand for clinical research
- 3.3.1.3. Globalization of clinical trials
- 3.3.2. Market restraint analysis
- 3.3.2.1. Communication errors between sites and principal investigators
- 3.3.2.2. Complexities in clinical studies and research procedures
- 3.3.1. Market driver analysis
- 3.4. Clinical Trial Investigative Site Network Market Analysis Tools
- 3.4.1. Industry Analysis - Porter's
- 3.4.2. PESTEL Analysis
- 3.4.3. Major Deals & Strategic Alliances Analysis
- 3.5. Covid-19 Impact Analysis and Reformation Strategies
Chapter 4. Clinical Trial Investigative Site Network Market: Therapeutic Areas Estimates & Trend Analysis
- 4.1. Definitions and Scope
- 4.2. Clinical Trial Investigative Site Network Market Share, 2021 & 2030
- 4.2.1. Oncology
- 4.2.1.1. Oncology market estimates and forecast 2018 to 2030 (USD Million)
- 4.2.2. Cardiology
- 4.2.2.1. Cardiology market estimates and forecast 2018 to 2030 (USD Million)
- 4.2.3. CNS
- 4.2.3.1. CNS market estimates and forecast 2018 to 2030 (USD Million)
- 4.2.4. Pain Management
- 4.2.4.1. Pain management market estimates and forecast 2018 to 2030 (USD Million)
- 4.2.5. Endocrine
- 4.2.5.1. Endocrine market estimates and forecast 2018 to 2030 (USD Million)
- 4.2.6. Others
- 4.2.6.1. Others market estimates and forecast 2018 to 2030 (USD Million)
- 4.2.1. Oncology
Chapter 5. Clinical Trial Investigative Site Network Market: Phase Estimates & Trend Analysis
- 5.1. Definitions and Scope
- 5.2. Clinical Trial Investigative Site Network Market Share, 2021 & 2030
- 5.2.1. Phase I
- 5.2.1.1. Phase I market estimates and forecast 2018 to 2030 (USD Million)
- 5.2.2. Phase II
- 5.2.2.1. Phase II market estimates and forecast 2018 to 2030 (USD Million)
- 5.2.3. Phase III
- 5.2.3.1. Phase III market estimates and forecast 2018 to 2030 (USD Million)
- 5.2.4. Phase IV
- 5.2.4.1. Phase IV market estimates and forecast 2018 to 2030 (USD Million)
- 5.2.1. Phase I
Chapter 6. Clinical Trial Investigative Site Network Market: End-use Estimates & Trend Analysis
- 6.1. Definitions and Scope
- 6.2. Clinical Trial Investigative Site Network Market Share, 2021 & 2030
- 6.2.1. Sponsor
- 6.2.1.1. Sponsors market estimates and forecast 2018 to 2030 (USD Million)
- 6.2.2. CRO
- 6.2.2.1. CRO market estimates and forecast 2018 to 2030 (USD Million)
- 6.2.1. Sponsor
Chapter 7. Clinical Trial Investigative Site Network Market: Regional Estimates & Trend Analysis
- 7.1. Regional market share analysis, 2021 & 2030
- 7.2. North America
- 7.2.1. U.S.
- 7.2.1.1. U.S. Market estimates and forecast, 2018 - 2030
- 7.2.2. Canada
- 7.2.2.1. Canada Market estimates and forecast, 2018 - 2030
- 7.2.1. U.S.
- 7.3. Europe
- 7.3.1. U.K.
- 7.3.1.1. U.K. Market estimates and forecast, 2018 - 2030
- 7.3.2. Germany
- 7.3.2.1. Germany Market estimates and forecast, 2018 - 2030
- 7.3.3. France
- 7.3.3.1. France Market estimates and forecast, 2018 - 2030
- 7.3.4. Italy
- 7.3.4.1. Italy Market estimates and forecast, 2018 - 2030
- 7.3.5. Spain
- 7.3.5.1. Spain Market estimates and forecast, 2018 - 2030
- 7.3.6. The Netherlands
- 7.3.6.1. The Netherlands Market estimates and forecast, 2018 - 2030
- 7.3.7. Sweden
- 7.3.7.1. Sweden Market estimates and forecast, 2018 - 2030
- 7.3.8. Switzerland
- 7.3.8.1. Switzerland Market estimates and forecast, 2018 - 2030
- 7.3.9. Russia
- 7.3.9.1. Russia Market estimates and forecast, 2018 - 2030
- 7.3.10. Belgium
- 7.3.10.1. Belgium Market estimates and forecast, 2018 - 2030
- 7.3.1. U.K.
- 7.4. Asia Pacific
- 7.4.1. Japan
- 7.4.1.1. Japan Market estimates and forecast, 2018 - 2030
- 7.4.2. China
- 7.4.2.1. China Market estimates and forecast, 2018 - 2030
- 7.4.3. India
- 7.4.3.1. India Market estimates and forecast, 2018 - 2030
- 7.4.4. Australia
- 7.4.4.1. Australia Market estimates and forecast, 2018 - 2030
- 7.4.5. South Korea
- 7.4.5.1. South Korea Market estimates and forecast, 2018 - 2030
- 7.4.6. Thailand
- 7.4.6.1. Thailand Market estimates and forecast, 2018 - 2030
- 7.4.7. Malaysia
- 7.4.7.1. Malaysia Market estimates and forecast, 2018 - 2030
- 7.4.8. New Zealand
- 7.4.8.1. New Zealand Market estimates and forecast, 2018 - 2030
- 7.4.9. Philippines
- 7.4.9.1. Philippines Market estimates and forecast, 2018 - 2030
- 7.4.10. Singapore
- 7.4.10.1. Singapore Market estimates and forecast, 2018 - 2030
- 7.4.1. Japan
- 7.5. Latin America
- 7.5.1. Brazil
- 7.5.1.1. Brazil Market estimates and forecast, 2018 - 2030
- 7.5.2. Mexico
- 7.5.2.1. Mexico Market estimates and forecast, 2018 - 2030
- 7.5.3. Argentina
- 7.5.3.1. Argentina Market estimates and forecast, 2018 - 2030
- 7.5.4. Colombia
- 7.5.4.1. Colombia Market estimates and forecast, 2018 - 2030
- 7.5.5. Chile
- 7.5.5.1. Chile Market estimates and forecast, 2018 - 2030
- 7.5.1. Brazil
- 7.6. MEA
- 7.6.1. South Africa
- 7.6.1.1. South Africa Market estimates and forecast, 2018 - 2030
- 7.6.2. Saudi Arabia
- 7.6.2.1. Saudi Arabia Market estimates and forecast, 2018 - 2030
- 7.6.3. UAE
- 7.6.3.1. UAE Market estimates and forecast, 2018 - 2030
- 7.6.4. Israel
- 7.6.4.1. Israel Market estimates and forecast, 2018 - 2030
- 7.6.5. Egypt
- 7.6.5.1. Egypt Market estimates and forecast, 2018 - 2030
- 7.6.1. South Africa
Chapter 8. Competitive Analysis
- 8.1. Recent Developments & Impact Analysis, By Key Market Participant
- 8.2. Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
- 8.3. Participant Categorization
- 8.4. Vendor Landscape
- 8.4.1. List of Key Service Providers
- 8.4.2. Market Differentiators
- 8.5. Market share analysis
Chapter 9. Competitive Landscape
- 9.1. Company Profiles
- 9.1.1. ICON plc
- 9.1.1.1. Company overview
- 9.1.1.2. Product benchmarking
- 9.1.1.3. Strategic initiatives
- 9.1.2. MERIDIAN CLINICAL RESEARCH
- 9.1.2.1. Company overview
- 9.1.2.2. Financial performance
- 9.1.2.3. Product benchmarking
- 9.1.2.4. Strategic initiatives
- 9.1.3. IQVIA Inc.
- 9.1.3.1. Company overview
- 9.1.3.2. Financial performance
- 9.1.3.3. Product benchmarking
- 9.1.3.4. Strategic initiatives
- 9.1.4. Clinedge
- 9.1.4.1. Company overview
- 9.1.4.2. Financial performance
- 9.1.4.3. Product benchmarking
- 9.1.4.4. Strategic initiatives
- 9.1.5. WCG
- 9.1.5.1. Company overview
- 9.1.5.2. Financial performance
- 9.1.5.3. Product benchmarking
- 9.1.5.4. Strategic initiatives
- 9.1.6. ClinChoice
- 9.1.6.1. Company overview
- 9.1.6.2. Financial performance
- 9.1.6.3. Product benchmarking
- 9.1.6.4. Strategic initiatives
- 9.1.7. Access Clinical Research
- 9.1.7.1. Company overview
- 9.1.7.2. Financial performance
- 9.1.7.3. Product benchmarking
- 9.1.7.4. Strategic initiatives
- 9.1.8. FOMAT Medical Research INC.
- 9.1.8.1. Company overview
- 9.1.8.2. Financial performance
- 9.1.8.3. Product benchmarking
- 9.1.8.4. Strategic initiatives
- 9.1.9. SGS SA
- 9.1.9.1. Company overview
- 9.1.9.2. Financial performance
- 9.1.9.3. Product benchmarking
- 9.1.9.4. Strategic initiatives
- 9.1.10. KV Clinical
- 9.1.10.1. Company overview
- 9.1.10.2. Financial performance
- 9.1.10.3. Product benchmarking
- 9.1.10.4. Strategic initiatives
- 9.1.11. SMO-Pharmina
- 9.1.11.1. Company overview
- 9.1.11.2. Financial performance
- 9.1.11.3. Product benchmarking
- 9.1.11.4. Strategic initiatives
- 9.1.12. Xylem Clinical Research
- 9.1.12.1. Company overview
- 9.1.12.2. Financial performance
- 9.1.12.3. Product benchmarking
- 9.1.12.4. Strategic initiatives
- 9.1.1. ICON plc
Product Code: GVR-4-68039-986-6
List of Tables
- Table 1 List of secondary sources
- Table 2 List of Abbreviations
List of Figures
- Fig. 1 Market research process
- Fig. 2 Information procurement
- Fig. 3 Primary research pattern
- Fig. 4 Market research approaches
- Fig. 5 Value-chain-based sizing & forecasting
- Fig. 6 QFD modeling for market share assessment
- Fig. 7 Market formulation & validation
- Fig. 8 Commodity flow analysis
- Fig. 9 Volume Price Analysis
- Fig. 10 Clinical Trial Investigative Site Network market snapshot (2021)
- Fig. 11 Clinical Trial Investigative Site Network market segmentation
- Fig. 12 Market driver relevance analysis (Current & future impact)
- Fig. 13 Market restraint relevance analysis (Current & future impact)
- Fig. 14 Penetration & growth prospect mapping
- Fig. 15 Porter's five forces analysis
- Fig. 16 SWOT analysis, by factor (political & legal, economic and technological)
- Fig. 17 Clinical Trial Investigative Site Network market therapeutic area outlook: Segment dashboard
- Fig. 18 Clinical Trial Investigative Site Network market: therapeutic area movement analysis
- Fig. 19 Oncology market, 2018 - 2030 (USD Million)
- Fig. 20 Cardiology market, 2018 - 2030 (USD Million)
- Fig. 21 CNS market, 2018 - 2030 (USD Million)
- Fig. 22 Pain Management market, 2018 - 2030 (USD Million)
- Fig. 23 Endocrine market, 2018 - 2030 (USD Million)
- Fig. 24 Others market, 2018 - 2030 (USD Million)
- Fig. 25 Clinical Trial Investigative Site Network market phase outlook: Segment dashboard
- Fig. 26 Clinical Trial Investigative Site Network market phase outlook: Segment dashboard
- Fig. 27 Phase I market, 2018 - 2030 (USD Million)
- Fig. 28 Phase II market, 2018 - 2030 (USD Million)
- Fig. 29 Phase III market, 2018 - 2030 (USD Million)
- Fig. 30 Phase IV market, 2018 - 2030 (USD Million)
- Fig. 31 Clinical Trial Investigative Site Network market end use outlook: Segment dashboard
- Fig. 32 Clinical Trial Investigative Site Network market: End use movement analysis
- Fig. 33 Spionsor market, 2018 - 2030 (USD Million)
- Fig. 34 CRO market, 2018 - 2030 (USD Million)
- Fig. 35 Regional market: Key takeaways
- Fig. 36 Regional outlook, 2021 & 2030
- Fig. 37 North America market, 2018 - 2030 (USD Million)
- Fig. 38 U.S. market, 2018 - 2030 (USD Million)
- Fig. 39 Canada market, 2018 - 2030 (USD Million)
- Fig. 40 Europe market, 2018 - 2030 (USD Million)
- Fig. 41 U.K. market, 2018 - 2030 (USD Million)
- Fig. 42 Germany market, 2018 - 2030 (USD Million)
- Fig. 43 France market, 2018 - 2030 (USD Million)
- Fig. 44 Italy market, 2018 - 2030 (USD Million)
- Fig. 45 Spain market, 2018 - 2030 (USD Million)
- Fig. 46 The Netherlands market, 2018 - 2030 (USD Million)
- Fig. 47 Belgium market, 2018 - 2030 (USD Million)
- Fig. 48 Sweden market, 2018 - 2030 (USD Million)
- Fig. 49 Switzerland market, 2018 - 2030 (USD Million)
- Fig. 49 Russia market, 2018 - 2030 (USD Million)
- Fig. 51 Asia Pacific market, 2018 - 2030 (USD Million)
- Fig. 52 China market, 2018 - 2030 (USD Million)
- Fig. 53 India market, 2018 - 2030 (USD Million)
- Fig. 54 Japan market, 2018 - 2030 (USD Million)
- Fig. 55 Australia market, 2018 - 2030 (USD Million)
- Fig. 56 South Korea market, 2018 - 2030 (USD Million)
- Fig. 57 Malaysia market, 2018 - 2030 (USD Million)
- Fig. 58 New Zealand market, 2018 - 2030 (USD Million)
- Fig. 59 Philippines market, 2018 - 2030 (USD Million)
- Fig. 60 Thailand market, 2018 - 2030 (USD Million)
- Fig. 61 Singapore market, 2018 - 2030 (USD Million)
- Fig. 62 South Korea market, 2018 - 2030 (USD Million)
- Fig. 63 Latin America market, 2018 - 2030 (USD Million)
- Fig. 64 Brazil market, 2018 - 2030 (USD Million)
- Fig. 65 Mexico market, 2018 - 2030 (USD Million)
- Fig. 66 Argentina market, 2018 - 2030 (USD Million)
- Fig. 67 Colombia market, 2018 - 2030 (USD Million)
- Fig. 68 Chile market, 2018 - 2030 (USD Million)
- Fig. 69 MEA market, 2018 - 2030 (USD Million)
- Fig. 70 South Africa market, 2018 - 2030 (USD Million)
- Fig. 71 Saudi Arabia market, 2018 - 2030 (USD Million)
- Fig. 72 Israel market, 2018 - 2030 (USD Million)
- Fig. 73 Egypt market, 2018 - 2030 (USD Million)
- Fig. 74 UAE market, 2018 - 2030 (USD Million)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.